Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-1 | 19 | 2024 | 540 | 3.000 |
Why?
|
Vimentin | 3 | 2018 | 255 | 1.090 |
Why?
|
Breast Neoplasms | 30 | 2023 | 21017 | 0.860 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2018 | 1085 | 0.680 |
Why?
|
Receptor, erbB-2 | 12 | 2021 | 2557 | 0.550 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 6 | 2014 | 359 | 0.530 |
Why?
|
Neoplastic Stem Cells | 8 | 2022 | 1349 | 0.520 |
Why?
|
Interferon-gamma | 2 | 2022 | 3162 | 0.510 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2024 | 8552 | 0.500 |
Why?
|
Cadherins | 2 | 2018 | 903 | 0.450 |
Why?
|
Neuroendocrine Cells | 2 | 2022 | 62 | 0.380 |
Why?
|
BRCA1 Protein | 2 | 2015 | 1158 | 0.370 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 4 | 2016 | 164 | 0.360 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2022 | 634 | 0.350 |
Why?
|
Transcription Factors | 8 | 2023 | 12129 | 0.350 |
Why?
|
Receptors, Progesterone | 9 | 2015 | 1129 | 0.330 |
Why?
|
Cell Line, Tumor | 15 | 2024 | 16986 | 0.320 |
Why?
|
Receptors, Estrogen | 9 | 2015 | 2208 | 0.310 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9420 | 0.310 |
Why?
|
Antigens, CD | 1 | 2018 | 4001 | 0.290 |
Why?
|
Immunohistochemistry | 12 | 2021 | 11076 | 0.280 |
Why?
|
Loss of Heterozygosity | 3 | 2015 | 662 | 0.270 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2020 | 339 | 0.270 |
Why?
|
Leukemia, Myeloid | 2 | 2005 | 694 | 0.250 |
Why?
|
GATA3 Transcription Factor | 2 | 2016 | 154 | 0.240 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2024 | 48 | 0.230 |
Why?
|
Lymphatic Metastasis | 7 | 2018 | 2915 | 0.230 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3801 | 0.230 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6935 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2017 | 9280 | 0.230 |
Why?
|
STAT1 Transcription Factor | 2 | 2024 | 341 | 0.220 |
Why?
|
Acrylamides | 1 | 2023 | 260 | 0.190 |
Why?
|
Prognosis | 20 | 2020 | 29629 | 0.190 |
Why?
|
Aromatase Inhibitors | 3 | 2016 | 513 | 0.190 |
Why?
|
Disease Progression | 3 | 2024 | 13510 | 0.190 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 592 | 0.190 |
Why?
|
Kaplan-Meier Estimate | 6 | 2018 | 6484 | 0.190 |
Why?
|
Receptors, Notch | 2 | 2024 | 743 | 0.190 |
Why?
|
DNA Methylation | 2 | 2015 | 4399 | 0.190 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3877 | 0.180 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2057 | 0.170 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3617 | 0.170 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2895 | 0.170 |
Why?
|
Interferons | 1 | 2023 | 706 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 727 | 0.160 |
Why?
|
Humans | 69 | 2024 | 761572 | 0.160 |
Why?
|
Neoplasm Invasiveness | 4 | 2017 | 3597 | 0.160 |
Why?
|
Tamoxifen | 2 | 2013 | 965 | 0.160 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 113 | 0.160 |
Why?
|
DNA-Binding Proteins | 7 | 2024 | 9610 | 0.160 |
Why?
|
Signal Transduction | 10 | 2024 | 23447 | 0.160 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 4 | 2014 | 57 | 0.160 |
Why?
|
Video Recording | 1 | 2023 | 967 | 0.150 |
Why?
|
NF-kappa B | 2 | 2024 | 2490 | 0.150 |
Why?
|
Leukemia | 3 | 2014 | 1522 | 0.150 |
Why?
|
Exosomes | 1 | 2023 | 424 | 0.150 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2022 | 328 | 0.150 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 423 | 0.150 |
Why?
|
Pneumonectomy | 2 | 2017 | 1119 | 0.140 |
Why?
|
Spores, Bacterial | 1 | 2017 | 113 | 0.140 |
Why?
|
Female | 43 | 2024 | 392686 | 0.140 |
Why?
|
Wound Closure Techniques | 1 | 2018 | 87 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11742 | 0.140 |
Why?
|
Metaplasia | 1 | 2017 | 322 | 0.140 |
Why?
|
Japan | 6 | 2020 | 1378 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13382 | 0.130 |
Why?
|
Phyllodes Tumor | 1 | 2016 | 53 | 0.130 |
Why?
|
Esophageal Neoplasms | 3 | 2019 | 1654 | 0.130 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2016 | 293 | 0.130 |
Why?
|
Indoles | 1 | 2023 | 1833 | 0.120 |
Why?
|
Axilla | 1 | 2018 | 624 | 0.120 |
Why?
|
Retroviridae | 3 | 2007 | 850 | 0.120 |
Why?
|
Information Dissemination | 1 | 2023 | 1126 | 0.120 |
Why?
|
Microsatellite Instability | 2 | 2016 | 716 | 0.120 |
Why?
|
Menstrual Cycle | 1 | 2018 | 539 | 0.120 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2231 | 0.120 |
Why?
|
Cytidine Deaminase | 1 | 2016 | 243 | 0.120 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2014 | 46 | 0.120 |
Why?
|
Bacillus subtilis | 1 | 2017 | 351 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5315 | 0.120 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11122 | 0.120 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1120 | 0.120 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 572 | 0.110 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 1459 | 0.110 |
Why?
|
RNA-Binding Proteins | 3 | 2024 | 1897 | 0.110 |
Why?
|
Chromatin | 2 | 2023 | 2961 | 0.110 |
Why?
|
Neoplasm Staging | 8 | 2017 | 11121 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2024 | 10448 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 412 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1626 | 0.110 |
Why?
|
Middle Aged | 29 | 2020 | 220920 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1241 | 0.110 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1147 | 0.110 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2013 | 132 | 0.110 |
Why?
|
Esophagectomy | 2 | 2014 | 468 | 0.110 |
Why?
|
DNA Damage | 1 | 2023 | 2449 | 0.110 |
Why?
|
Immune System | 1 | 2018 | 796 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2020 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5790 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 3 | 2010 | 3397 | 0.100 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2012 | 92 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6346 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1516 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 2 | 2010 | 1363 | 0.100 |
Why?
|
Laryngectomy | 1 | 2014 | 243 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 158 | 0.100 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
Fanconi Anemia | 1 | 2014 | 324 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1271 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 954 | 0.100 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 151 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 738 | 0.100 |
Why?
|
Disease-Free Survival | 7 | 2016 | 6815 | 0.090 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2811 | 0.090 |
Why?
|
Pyrimidines | 1 | 2023 | 3028 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1436 | 0.090 |
Why?
|
Pharynx | 1 | 2014 | 432 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2016 | 12794 | 0.090 |
Why?
|
Hemangioblasts | 1 | 2010 | 28 | 0.090 |
Why?
|
Femur Neck | 1 | 2012 | 314 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1728 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12463 | 0.090 |
Why?
|
SOXB1 Transcription Factors | 2 | 2024 | 286 | 0.090 |
Why?
|
Mutation | 6 | 2024 | 30054 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4026 | 0.090 |
Why?
|
Ganglia, Spinal | 2 | 2003 | 526 | 0.090 |
Why?
|
Neoplasms | 4 | 2024 | 22173 | 0.090 |
Why?
|
Mice | 17 | 2024 | 81533 | 0.080 |
Why?
|
Cell Adhesion Molecules | 2 | 2013 | 1601 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1052 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2450 | 0.080 |
Why?
|
Premenopause | 1 | 2013 | 1039 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4513 | 0.080 |
Why?
|
Glutamine | 1 | 2012 | 577 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2020 | 5799 | 0.080 |
Why?
|
Mastectomy | 1 | 2017 | 1822 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 785 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 646 | 0.080 |
Why?
|
Hernia | 1 | 2008 | 68 | 0.080 |
Why?
|
Ki-67 Antigen | 3 | 2015 | 629 | 0.070 |
Why?
|
Sciatic Neuropathy | 1 | 2008 | 76 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4575 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2118 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1148 | 0.070 |
Why?
|
Echinococcus granulosus | 1 | 2007 | 11 | 0.070 |
Why?
|
Echinococcosis, Hepatic | 1 | 2007 | 24 | 0.070 |
Why?
|
Leukemia, Experimental | 1 | 2007 | 225 | 0.070 |
Why?
|
Receptors, Androgen | 1 | 2013 | 1079 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1642 | 0.070 |
Why?
|
Terminal Repeat Sequences | 1 | 2007 | 70 | 0.070 |
Why?
|
Animals | 20 | 2024 | 168467 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2013 | 946 | 0.070 |
Why?
|
Adult | 15 | 2020 | 221203 | 0.070 |
Why?
|
Retroviridae Infections | 1 | 2007 | 147 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2024 | 988 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2009 | 2827 | 0.070 |
Why?
|
Aged | 15 | 2020 | 169310 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3466 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1756 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7391 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3879 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10773 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2013 | 5869 | 0.060 |
Why?
|
Gene Dosage | 2 | 2012 | 1218 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20099 | 0.060 |
Why?
|
Colony-Forming Units Assay | 1 | 2005 | 352 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2046 | 0.060 |
Why?
|
Genes, ras | 1 | 2007 | 654 | 0.060 |
Why?
|
Pleural Neoplasms | 1 | 2009 | 609 | 0.060 |
Why?
|
Axons | 2 | 2003 | 1674 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2020 | 58986 | 0.060 |
Why?
|
Intestinal Obstruction | 1 | 2008 | 432 | 0.060 |
Why?
|
Mice, Nude | 2 | 2022 | 3614 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5369 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2911 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2007 | 397 | 0.060 |
Why?
|
Tumor Virus Infections | 1 | 2007 | 438 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2009 | 897 | 0.060 |
Why?
|
RNA-Binding Protein FUS | 1 | 2024 | 76 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2917 | 0.050 |
Why?
|
Cell Survival | 3 | 2024 | 5791 | 0.050 |
Why?
|
Receptor, trkC | 1 | 2003 | 63 | 0.050 |
Why?
|
Ligands | 2 | 2023 | 3272 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1762 | 0.050 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 656 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 95 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2020 | 4280 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5821 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2007 | 1494 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6075 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2014 | 404 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2023 | 321 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11530 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2005 | 727 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2022 | 116 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2898 | 0.050 |
Why?
|
Proprioception | 1 | 2002 | 133 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 2919 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2023 | 2456 | 0.050 |
Why?
|
Treatment Outcome | 10 | 2019 | 64684 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2017 | 1115 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39107 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3514 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1595 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2002 | 498 | 0.040 |
Why?
|
POU Domain Factors | 1 | 2020 | 47 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8528 | 0.040 |
Why?
|
Synaptophysin | 1 | 2020 | 139 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2713 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3551 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2002 | 604 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2020 | 223 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 719 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2023 | 1069 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2014 | 22172 | 0.040 |
Why?
|
Male | 15 | 2024 | 360842 | 0.040 |
Why?
|
Hydrostatic Pressure | 1 | 2017 | 98 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 454 | 0.040 |
Why?
|
Epithelium | 1 | 2002 | 1603 | 0.040 |
Why?
|
Asia | 1 | 2018 | 619 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5672 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 360 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6132 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1349 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 398 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20571 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2020 | 1699 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3396 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2020 | 80646 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2538 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 851 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 583 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2510 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 727 | 0.030 |
Why?
|
Base Sequence | 3 | 2011 | 12441 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3839 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4465 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1787 | 0.030 |
Why?
|
Endothelium | 1 | 2016 | 765 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5305 | 0.030 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 146 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2013 | 79 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1136 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2201 | 0.030 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3201 | 0.030 |
Why?
|
Taxoids | 1 | 2017 | 668 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2018 | 732 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2872 | 0.030 |
Why?
|
Cleidocranial Dysplasia | 1 | 2012 | 18 | 0.030 |
Why?
|
Postoperative Care | 1 | 2019 | 1468 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 17635 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15601 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2018 | 955 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17904 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1250 | 0.030 |
Why?
|
Color | 1 | 2013 | 299 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1157 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.020 |
Why?
|
Gene Deletion | 2 | 2014 | 2665 | 0.020 |
Why?
|
Prostate | 1 | 2020 | 1773 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15633 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2015 | 1062 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2010 | 9541 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 2397 | 0.020 |
Why?
|
Hot Temperature | 1 | 2017 | 1440 | 0.020 |
Why?
|
Femoral Neck Fractures | 1 | 2012 | 142 | 0.020 |
Why?
|
Phenobarbital | 1 | 2011 | 191 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2013 | 351 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2005 | 1749 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 670 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1998 | 0.020 |
Why?
|
Mice, Knockout | 4 | 2009 | 14416 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15266 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2416 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2014 | 983 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2010 | 115 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3113 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2012 | 360 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 39970 | 0.020 |
Why?
|
Chondroblastoma | 1 | 2009 | 47 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1967 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22176 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2005 | 18253 | 0.020 |
Why?
|
Thoracoscopy | 1 | 2009 | 181 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9353 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2020 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2910 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 1092 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2321 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12059 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3094 | 0.020 |
Why?
|
Image Enhancement | 1 | 2018 | 2885 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59255 | 0.020 |
Why?
|
Hypertonic Solutions | 1 | 2007 | 82 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2571 | 0.020 |
Why?
|
Radiotherapy | 1 | 2014 | 1499 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4124 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1258 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2297 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2011 | 805 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3807 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2009 | 471 | 0.020 |
Why?
|
Ultrasonography | 2 | 2012 | 5972 | 0.020 |
Why?
|
Ascites | 1 | 2008 | 338 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 481 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 4989 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3416 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1993 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 195 | 0.020 |
Why?
|
Punctures | 1 | 2007 | 366 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5311 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13642 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2865 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2016 | 2827 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 5496 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2005 | 120 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9469 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1626 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1784 | 0.010 |
Why?
|
GATA1 Transcription Factor | 1 | 2005 | 296 | 0.010 |
Why?
|
Rare Diseases | 1 | 2009 | 622 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6426 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6766 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5774 | 0.010 |
Why?
|
Peru | 1 | 2007 | 891 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4319 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9463 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2690 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11904 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1302 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4915 | 0.010 |
Why?
|
Motor Skills Disorders | 1 | 2002 | 89 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2002 | 364 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2003 | 574 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1118 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 651 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3085 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2005 | 755 | 0.010 |
Why?
|
Ataxia | 1 | 2003 | 306 | 0.010 |
Why?
|
Ethanol | 1 | 2007 | 1324 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12954 | 0.010 |
Why?
|
Risk Factors | 2 | 2017 | 74213 | 0.010 |
Why?
|
Insulin | 1 | 2014 | 6597 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2003 | 1529 | 0.010 |
Why?
|
Apoptosis | 2 | 2007 | 9489 | 0.010 |
Why?
|
Hyperplasia | 1 | 2002 | 1152 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10090 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 838 | 0.010 |
Why?
|
Posture | 1 | 2003 | 957 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3449 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7593 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16592 | 0.010 |
Why?
|
Stomach | 1 | 2002 | 696 | 0.010 |
Why?
|
Leukocytes | 1 | 2005 | 2026 | 0.010 |
Why?
|
Radiography | 1 | 2008 | 6965 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15936 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2002 | 2677 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9177 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10194 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1674 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12725 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2391 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12947 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7858 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3792 | 0.010 |
Why?
|
Spinal Cord | 1 | 2003 | 1819 | 0.010 |
Why?
|
Aging | 1 | 2013 | 8711 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 1962 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54426 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21355 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36429 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12148 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 23996 | 0.000 |
Why?
|
Child | 1 | 2016 | 80156 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 88324 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23741 | 0.000 |
Why?
|